查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837213

手术服市场按产品类型、无菌性、材料、防护等级、应用、最终用户和分销管道划分 - 全球预测 2025-2032

Surgical Gown Market by Product Type, Sterility, Material, Protection Level, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年手术服市场规模将成长至 21.9 亿美元，复合年增长率为 4.95%。

主要市场统计数据
基准年2024年 14.8亿美元
预计2025年 15.5亿美元
预测年份：2032年 21.9亿美元
复合年增长率（%） 4.95%

全面介绍将手术服定位为关键的临床安全设备，同时建立不断发展的安全、监管和采购动态

手术服在维持临床无菌、保护手术团队以及保障侵入性手术过程中的患者预后方面发挥核心作用。材料科学、感染预防通讯协定和法律规范的进步，已将罩衣基本的防护服提升为手术全期风险管理的关键要素。因此，罩衣的采购决策与临床绩效指标、职业安全标准和供应链连续性计画的关联性日益增强。

随着时间的推移，临床证据、标准制定机构和製造能力之间的相互作用推动了防护服的屏障性能、穿戴舒适度和环境永续性的逐步提升。这些发展影响临床医生的偏好、采购标准以及手术室调度和处理量的营运计算。因此，对于医院管理人员、采购主管和产品开发人员而言，了解产品格局以及影响设计、采用和分销的因素至关重要，他们希望将罩衣的选择与安全目标和成本现实相结合。

本执行摘要概述了影响罩衣选择和供应动态的关键驱动因素和压力，强调了细分市场和区域差异，摘要了近期关税行动的影响，并为试图应对不断变化的监管和商业环境的利益相关人员提供了实用建议。其目标是为领导者提供简洁易懂、切实可行的见解，以支持他们在临床、采购和策略规划领域做出明智的决策。

临床期望、材料创新、日益严格的法规以及供应链弹性如何重新定义手术服的设计、采购和生命週期决策

在临床期望、製造创新和供应链韧性等因素的共同推动下，手术服市场正在经历一场变革。不织布技术和复合层压材料的创新，创造出了兼顾阻隔性能和透气性的材料，能够在不影响防护性能的情况下延长连续穿着时间。同时，接缝结构、贴合工程和人体工学设计的进步，正在减轻临床医生的疲劳，并提高操作灵活性。

不断变化的法规和标准提高了阻隔有效性和耐液体性能的测试和传达标准，促使製造商投资于更严格的测试和更透明的性能声明。同时，对环境影响和报废产品处置的审查日益严格，也推动了人们对可重复使用解决方案和可回收材料系统的兴趣。

供应链动态也正在从即时商品化模式转变为混合弹性模式，该模式优先考虑多元化采购、近岸外包和库存缓衝。医疗系统更重视供应商合格、紧急时应对计画和合约条款，以确保在地缘政治动盪或需求激增期间的供应连续性。总而言之，这些转型迫使相关人员重新评估采购标准、临床评估工作流程和长期供应商伙伴关係，以追求连续性和临床表现。

评估近期关税措施对筹资策略、供应商本地化、总成本和罩衣供应连续性的多方面影响

近期的关税调整为购买手术服及相关防护衣的机构带来了新的成本和采购考量。关税增加了到岸成本，并促使买家寻找替代供应商、替代材料或替代通路以减轻财务影响，这给采购预算带来了压力。实际上，这些动态再形成了谈判能力、合约结构和总拥有成本的计算。

除了直接的成本影响外，关税引发的变化往往会加速供应商多元化和区域筹资策略。对于製造商而言，关税可能促使其重新评估其製造布局，包括投资区域产能、与本地加工商建立策略联盟以及修改供应协议以保持竞争力。这些因应措施会对下游产生影响，包括前置作业时间、品管以及长期供应关係的稳定性。

此外，关税的累积效应往往会凸显供应链透明度的价值。买家更加重视供应商的可追溯性、合格证书以及解决关税转嫁和成本分摊机制的合约保护。临床上，相关人员必须在成本控制与不妥协的屏障性能和法规合规性之间取得平衡，以确保关税降低策略不会带来不可接受的临床风险。最终，除了对价格的直接影响外，关税还会促使采购行为、合约条款和製造在地化决策发生结构性变化。

关键细分资讯解释了产品类型、无菌性、材料化学、保护等级、应用、最终用户和通路动态如何推动采购和临床选择

细分揭示了不同的设计属性和使用如何影响临床选择和筹资策略。在从一次性和可重复使用的角度考虑产品类型时，购买者会权衡一次性产品的便利性和监管简易性，以及可重复使用纺织品系统（需要洗涤和灭菌基础设施）对环境和生命週期的影响。同样，非无菌手术服和无菌罩衣之间的灭菌分类也指导了基于手术风险状况的选择标准，其中罩衣仅罩衣需要无菌屏障的手术。

涤棉混纺面料经久耐用，穿着舒适，可洗涤后重复使用；聚乙烯涂层聚丙烯面料可提供更传统的层压阻隔；纺粘聚丙烯面料可提供基本的阻隔保护，且成本效益更高；纺粘-熔喷-纺粘结构则可提供更强的颗粒物和液体防护，适用于高风险环境。防护等级分类从1级（最低风险）到4级（高风险），这影响哪些罩衣结构适用于心血管外科、一般外科和整形外科应用，并决定着产品在手术通讯协定中的放置。

这是因为心血管手术通常要求最高的阻隔性和接缝性能，而普通外科手术可能优先考虑防护性和灵活性之间的平衡。在整形外科，由于手术的性质，耐用性和防水性尤其重要。最终使用者环境，如门诊手术中心、诊所和医院，表现出不同的采购情况。门诊手术中心通常倾向于成本效益和精简的物流，诊所可能需要对门诊病人手术进行较轻的防护，而医院通常要求更广泛的罩衣类型以涵盖不同的外科专业。无论是透过传统医疗保健供应商或集团采购组织进行线下销售，还是透过数位平台进行线上销售，分销管道都进一步影响了前置作业时间、价格透明度以及对利基或高级产品的获取。这种细分也反映在规范制定、临床评估流程和供应商选择标准。

采购框架、管理体制和製造足迹的地理差异如何影响罩衣的选择、供应商策略和临床采用模式

区域动态对整个美洲大陆的采购选择、法规遵循和供应商策略有着重大影响。在美洲，采购往往由大型综合医疗系统和集团采购组织推动，这些组织要求提供检验的绩效数据、可靠的供应连续性和清晰的监管文件。这种环境有利于能够提供综合增值服务的供应商，例如始终如一的品质、快速的履约以及临床教育和临床实验的现场支援。

在欧洲、中东和非洲，监管协调工作与各国不同的采购架构并存，导致供应商必须应对各种需求。这些地区的买家需要在集中式医院采购与国家和地区采购偏好之间取得平衡，而永续性要求和成本控制措施也推动了人们对可重复使用系统的兴趣。因此，供应商通常会客製化产品系列和支援服务，以满足监管要求和特定地区的营运限制。

在亚太地区，医疗基础设施的快速扩张、手术量的不断增长以及对本地製造能力的投资正在重塑供应商格局。该地区许多国家正在推行近岸外包策略，以缩短交货前置作业时间、管理外汇和关税风险，同时培养国内生产能力。因此，买家会遇到各种各样的供应商，他们的性价比各有不同，而製造商则透过投资于本地化的品质保证和法规合规流程来应对。这些地区差异凸显了筹资策略与当地管理体制、物流现况和临床实务模式一致的重要性。

竞争和供应商格局分析强调了产品创新、规模优势和服务整合如何决定采购优先事项和长期伙伴关係

大型製造商和经销商之间的竞争态势体现为创新主导的差异化、规模化的成本竞争以及服务导向的价值提案。那些专注于增强屏障、人体工学设计和永续材料的产品开发的市场参与企业往往会获得临床医生和安全委员会的支持，而大型製造商则利用供应的连续性和分销的广度来服务大型机构采购商和团体采购组织。

罩衣製造商与提供服务业者（包括灭菌实验室和专业经销商）之间的合作，打造出整合产品，简化了医院系统和门诊中心的实施。同时，专注于单一属性（例如增强透气性、抗菌处理或可回收材料）的利基市场参与企业的激增，正在扩大可用选项的范围，并使临床评估过程复杂化。能够展示强大的品质系统、整个供应链的可追溯性以及严格的第三方测试的供应商，将在优先考虑风险缓解和法规合规性的采购评估中拥有竞争优势。

对于商业性领袖而言，差异化日益不仅基于价格，还基于配套服务、临床培训和全生命週期责任制。这些能力使其能够与医疗机构的品质目标更加契合，减少实施摩擦，并支持在成本、性能和连续性之间取得平衡的长期合约关係。

为製造商、采购负责人和临床领导者提供可行的建议，以平衡手术服装的创新、采购弹性和生命週期管理。

为了保持韧性和临床完整性，产业领导者应采取多管齐下的策略，在创新、供应连续性和生命週期管理之间取得平衡。首先，投资于产品开发，优先考虑经过验证的阻隔性能、符合人体工学的贴合度以及在不损害临床防护的情况下减少环境影响的材料选择。其次，实现製造和采购布局的多元化，包括区域产能和合格的二级供应商，以降低与地缘政治和关税波动相关的营运风险。

第三，透过以结果为导向的合约加强供需关係，这些合约应包含绩效保证、约定的服务水准以及供应中断时的快速升级机制。第四，扩大临床参与项目，促进实际评估和临床医生回馈，以加速产品采用，并确保产品选择基于实际可用性数据。第五，推行生命週期策略，评估一次性和可重复使用方案对环境和营运的全面影响，包括在采用可重复使用解决方案时对灭菌和亚麻布管理进行投资。

最后，提高供应链文件和品质数据的透明度，增强采购决策的可信度。实施这些建议将有助于持续提升临床表现，降低对外部衝击的脆弱性，并使产品供应与机构不断变化的安全、永续性和成本效益优先事项保持一致。

一种透明的混合方法研究途径，结合初步访谈、标准化调查和情境测试来检验临床和供应链的发现

本研究综合采用混合方法，结合了一级和二级研究、严格的文献审查以及与临床和供应链相关人员的交叉检验。主要资讯包括与采购主管、无菌处理经理、各外科专科临床医生负责人以及製造品质负责人进行结构化访谈，以获得关于规格驱动因素、评估通讯协定和物流限制的第一手资料。这些讨论促成了对产品采用动态、临床使用问题和供应商绩效属性的定性评估。

我们的次要分析涵盖了标准文件、关于屏障性能和感染预防的同行评审文献、关于不织布技术和纺织品加工的行业白皮书，以及与手术服饰相关的监管指南。透过对这些资讯来源进行三角测量，我们确保我们的结论能够反映临床实践、产品性能证据和监管期望的共识。在整个研究过程中，我们专注于可追溯的来源、测试方法的检验以及产品声明与独立性能评估的一致性。

最后，我们透过情境分析对调查结果进行了压力测试，以探讨供应中断、资费调整以及临床需求突然变化对营运的影响。这种调查方法提供了可靠且可行的见解，同时也认识到进一步收集原始资料可以提供按专业和地区分類的更详细资讯。

策略结论强调了综合临床、营运和永续性影响，这些影响应指南未来的罩衣采购和产品开发。

总而言之，手术服正在超越其传统的一次性防护层角色，成为兼具临床安全、营运韧性和环境管理等重要战略意义的产品。材料创新、日益严格的法规以及供应链重组正在共同影响采购标准和临床医生的偏好。因此，组织必须采取一种综合的方法来选择罩衣，将阻隔性能、使用者舒适度、生命週期影响和供应商可靠性纳入考虑。

决策者应优先考虑合约保障措施，以确保供应的连续性，同时确保取得透明的绩效数据、严格的临床评估和技术创新。透过使采购实务与临床需求和营运实际情况一致，医疗保健机构可以降低程序风险，提高临床医生满意度，并增强抵御外部干扰的能力。製造商、医疗保健提供者和标准组织之间的持续合作对于推动产品设计、检验方法和永续实践的逐步改进至关重要，以跟上不断发展的外科手术实践。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将抗菌银奈米颗粒融入罩衣布料，增强感染控制
  • 开发可重复使用的手术罩衣，其表面具有自我消毒功能，可用于多个手术週期
  • 采用 3D 针织技术製造无缝罩衣，符合人体工学
  • 过渡到与放射线杀菌过程相容的认证 4 级灭菌罩衣
  • 适用于微创手术的防水透气罩衣的需求不断增加
  • 近距离场通讯标籤的广泛采用，可在医院供应链中实现即时罩衣追踪
  • 轻质复合 SMS 和纺粘织物混纺越来越多地被采用，以提高使用者的舒适度和保护性。

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 手术服市场（依产品类型）

  • 一次性的
  • 可重复使用的

第九章 手术服市场 不孕不育

  • 非无菌
  • 已灭菌

第 10 章 手术服市场：依材料

  • 聚酯纤维和棉混纺
  • 聚乙烯涂层聚丙烯
  • 纺粘聚丙烯
  • 纺粘-熔喷-纺粘

第11章 手术服市场（依防护等级）

  • 1级（最低风险）
  • 2级（低风险）
  • 3级（中度风险）
  • 4级（高风险）

第 12 章手术服市场：按应用

  • 心血管系统
  • 一般外科
  • 整形外科

第十三章 手术服市场（依最终用户）

  • 门诊手术中心
  • 诊所
  • 医院

第十四章 手术服市场（依通路）

  • 离线
  • 在线的

第十五章 手术服市场：按地区

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 手术服市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国手术服市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • Ahlstrom-Munksjo Oyj
    • Cardinal Health, Inc.
    • Delta Med SpA
    • Dispotech srl
    • Lohmann & Rauscher GmbH & Co. KG
    • Medica Europe BV
    • Medline Industries, Inc.
    • Molnlycke Health Care AB
    • Paul Hartmann AG
    • PRIMED Medical Products Inc.
    • Shanghai Medical Corporation
    • Steris Corporation
    • Thermo Fisher Scientific Inc.
    • Zhejiang Runtai Automation Technology Co.,Ltd.
    • ANSELL LTD
    • Kimberly-Clark Corporation
    • DuPont de Nemours, Inc.
    • B. Braun SE
    • Halyard Health, Inc. by Owens & Minor Inc.
    • TIDI Products, LLC
    • Priontex（Pty）Ltd
    • Sara Health Care Pvt Ltd
    • Winner Medical Co., Ltd.
Product Code: MRR-034B50030986

The Surgical Gown Market is projected to grow by USD 2.19 billion at a CAGR of 4.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.48 billion
Estimated Year [2025] USD 1.55 billion
Forecast Year [2032] USD 2.19 billion
CAGR (%) 4.95%

A comprehensive introduction that situates surgical gowns as vital clinical safeguards while framing evolving safety, regulatory, and procurement dynamics

Surgical gowns occupy a central role in maintaining clinical sterility, protecting surgical teams, and safeguarding patient outcomes during invasive procedures. Advances in material science, infection prevention protocols, and regulatory oversight have elevated the gown from a basic protective garment to a critical component of perioperative risk management. As such, procurement decisions about gowns increasingly intersect with clinical performance metrics, occupational safety standards, and supply chain continuity planning.

Over time, the interplay between clinical evidence, standards-setting bodies, and manufacturing capabilities has driven incremental improvements in barrier performance, wearer comfort, and environmental sustainability. These developments influence clinician preference, acquisition criteria, and the operational calculus of operating theater scheduling and throughput. Consequently, understanding the product landscape and the forces shaping design, adoption, and distribution is essential for hospital administrators, procurement leads, and product developers who aim to align gown choices with safety objectives and cost realities.

This executive synthesis frames the salient drivers and pressures reshaping gown selection and supply dynamics, highlights segmentation and regional differentials, summarizes the implications of recent tariff actions, and offers practical recommendations for stakeholders seeking to navigate an evolving regulatory and commercial environment. The objective is to equip leaders with concise, actionable insight that supports informed decisions across clinical, procurement, and strategic planning horizons.

How clinical expectations, material innovation, regulatory tightening, and supply chain resilience are jointly redefining surgical gown design, procurement, and lifecycle decisions

The surgical gown landscape is undergoing transformative shifts driven by converging forces in clinical expectations, manufacturing innovation, and supply chain resilience. Innovations in nonwoven technologies and composite laminates have yielded materials that balance barrier performance with breathability, enabling longer continuous wear times without compromising protection. Simultaneously, advances in seam construction, fit engineering, and design ergonomics are reducing clinician fatigue and improving dexterity, which in turn influences product adoption in high-acuity specialties.

Regulatory and standards changes are raising the bar for how barrier efficacy and fluid resistance are tested and communicated, prompting manufacturers to invest in higher-fidelity testing and more transparent performance claims. At the same time, increased scrutiny of environmental impact and end-of-life disposal is provoking greater interest in reusable solutions and recyclable material systems, although reusable options require investment in laundering infrastructure and chain-of-custody controls.

Supply chain dynamics are also shifting from just-in-time commoditization to a hybrid resilience model that prioritizes diversified sourcing, nearshoring, and inventory buffering. Health systems are placing greater emphasis on supplier qualification, contingency planning, and contractual terms that ensure continuity of supply during geopolitical disruptions or demand spikes. Taken together, these transformative shifts are compelling stakeholders to reassess procurement criteria, clinical evaluation workflows, and long-term vendor partnerships in pursuit of both continuity and clinical performance.

Assessing the multifaceted consequences of recent tariff actions on procurement strategy, supplier localization, and the total cost and continuity of gown supply

Recent tariff adjustments have introduced new cost and sourcing considerations for organizations that procure surgical gowns and associated protective apparel. Tariffs exert pressure on procurement budgets by increasing landed costs and incentivizing buyers to explore alternative suppliers, substitute materials, or different distribution channels in order to mitigate financial impacts. In practice, these dynamics reshape negotiation leverage, contract structures, and total cost of ownership calculations.

Beyond direct cost implications, tariff-driven shifts often accelerate supplier diversification and regional sourcing strategies, as purchasers seek to reduce exposure to tariff volatility and associated logistics constraints. For manufacturers, tariffs can prompt reassessment of manufacturing footprints, including investments in regional production capacity, strategic partnerships with local converters, and changes in supply agreements to preserve competitiveness. Such responses have downstream implications for lead times, quality control, and the stability of long-term supply relationships.

Additionally, the cumulative effect of tariff measures tends to highlight the value of transparency in the supply chain. Buyers place greater emphasis on supplier traceability, certificates of conformity, and contractual protections that address tariff pass-through and cost-sharing mechanisms. Clinically, stakeholders must balance cost containment with uncompromised barrier performance and regulatory compliance, ensuring that tariff mitigation strategies do not introduce unacceptable clinical risk. Ultimately, tariffs act as a catalyst for structural changes in sourcing behaviors, contract terms, and manufacturing localization decisions that extend beyond immediate price impacts.

Key segmentation intelligence that explains how product type, sterility, material chemistry, protection level, application, end user, and channel dynamics drive procurement and clinical selection

Segmentation reveals how distinct design attributes and use contexts shape clinical choice and procurement strategies. When product type is examined through the lens of disposable and reusable offerings, purchasers weigh single-use convenience and regulatory simplicity against the environmental and lifecycle implications that accompany reusable textile systems, which demand laundering and sterilization infrastructure. Similarly, sterility classification between non-sterile and sterile gowns guides selection criteria for procedure risk profiles, with sterile gowns reserved for surgeries where aseptic barriers are essential.

Material composition further differentiates performance and usability: polyester-cotton blends deliver durability and comfort for laundered reusables, polyethylene-coated polypropylene offers a more traditional laminated barrier, spunbond polypropylene provides basic barrier protection with enhanced cost-effectiveness, and spunbond-meltblown-spunbond constructions elevate particulate and fluid resistance for higher-risk environments. Protection level distinctions-ranging from Level 1 minimal risk through Level 4 high-risk-drive product placement within procedural protocols, influencing which gown constructions are acceptable for cardiovascular, general surgery, or orthopedic applications.

Application-specific needs introduce another layer of segmentation, as cardiovascular procedures often demand the highest barrier integrity and seam performance, whereas general surgery may prioritize a balance of protection and mobility. Orthopedic settings place a premium on durability and fluid repellency given the nature of the procedures. End-user environments such as ambulatory surgical centers, clinics, and hospitals exhibit different procurement profiles: ambulatory centers frequently favor cost-efficiency and streamlined logistics, clinics may require lighter protection for outpatient procedures, and hospitals typically mandate a broader range of gown types to cover diverse surgical specialties. Distribution channels, whether offline through traditional medical suppliers and group purchasing organizations or online via digital platforms, further shape lead times, pricing transparency, and the ability to access niche or premium products. Together, these segmentation dimensions inform specification development, clinical evaluation processes, and supplier selection criteria.

How geographic variations in procurement frameworks, regulatory regimes, and manufacturing footprints shape gown selection, supplier strategies, and clinical adoption patterns

Regional dynamics materially influence procurement choices, regulatory compliance, and supplier strategies across continents. In the Americas, procurement tends to be driven by large integrated health systems and group purchasing organizations that demand validated performance data, reliable supply continuity, and clear regulatory documentation. This environment favors suppliers that can provide consistent quality, rapid fulfillment, and integrated value services such as clinical education and on-site trial support.

In Europe, Middle East & Africa, regulatory harmonization efforts coexist with varied national procurement frameworks, resulting in a patchwork of requirements that suppliers must navigate. Buyers in these regions balance centralized hospital procurement with national and local purchasing preferences, and there is growing interest in reusable systems driven by sustainability mandates and cost containment initiatives. As a result, suppliers often tailor product portfolios and support services to meet both regulatory expectations and localized operational constraints.

Across Asia-Pacific, rapid expansion of healthcare infrastructure, increasing surgical volumes, and investments in regional manufacturing capacity are reshaping supplier landscapes. Many countries in the region pursue nearshoring strategies to reduce lead times and manage currency and tariff risk, while also fostering domestic production capabilities. Consequently, buyers encounter a broadened supplier set with varied price-performance trade-offs, and manufacturers are responding by investing in localized quality assurance and regulatory compliance processes. These regional differentials underscore the importance of aligning sourcing strategies with local regulatory regimes, logistics realities, and clinical practice patterns.

Competitive and supplier landscape analysis highlighting how product innovation, scale advantages, and service integration determine procurement preference and long-term partnerships

Competitive dynamics among leading manufacturers and distributors are characterized by a mix of innovation-driven differentiation, scale-based cost competition, and service-oriented value propositions. Market participants that invest in product development-focusing on barrier enhancement, ergonomic design, and sustainable materials-tend to capture preference among clinician champions and safety committees, while large-scale manufacturers leverage supply continuity and distribution breadth to serve major institutional buyers and group purchasing organizations.

Partnerships between gown producers and service providers, including sterile processing organizations and specialty distributors, create integrated offerings that simplify implementation for hospital systems and ambulatory centers. At the same time, a proliferation of niche entrants focusing on single attributes-such as enhanced breathability, antimicrobial finishes, or recyclable materials-has expanded the breadth of available options and complicated the clinical evaluation process. Suppliers capable of demonstrating robust quality systems, traceability across the supply chain, and rigorous third-party testing gain a competitive edge in procurement evaluations that prioritize risk mitigation and regulatory compliance.

For commercial leaders, differentiation increasingly relies on bundled services, clinical training, and total lifecycle accountability rather than on price alone. These capabilities enable closer alignment with institutional quality goals, reduce adoption friction, and support longer-term contracting relationships that balance cost, performance, and continuity.

Actionable recommendations for manufacturers, procurers, and clinical leaders to balance innovation, sourcing resilience, and lifecycle stewardship for surgical gowns

To remain resilient and clinically aligned, industry leaders should pursue a multi-pronged strategy that balances innovation, supply continuity, and lifecycle stewardship. First, invest in product development that prioritizes proven barrier performance, ergonomic fit, and material choices that reduce environmental impact without compromising clinical protection. Second, diversify manufacturing and sourcing footprints to include regional capacities and qualified secondary suppliers, thereby mitigating the operational risk associated with geopolitical and tariff volatility.

Third, strengthen supplier-buyer relationships through outcome-focused contracts that include performance guarantees, agreed service levels, and mechanisms for rapid escalation during supply disruptions. Fourth, expand clinical engagement programs that facilitate hands-on evaluations and clinician feedback loops to accelerate adoption and ensure that product selection is informed by real-world usability data. Fifth, pursue lifecycle strategies that evaluate the total environmental and operational implications of disposable versus reusable options, including investments in sterilization and linen management where reusable solutions are adopted.

Finally, adopt greater transparency in supply chain documentation and quality data so that procurement decisions can be made with confidence. Executing these recommendations will support sustained clinical performance, reduce vulnerability to external shocks, and align product offerings with evolving institutional priorities for safety, sustainability, and cost efficiency.

A transparent mixed-methods research approach integrating primary interviews, standards review, and scenario testing to validate clinical and supply chain findings

This research synthesis is grounded in a hybrid methodology combining primary and secondary inquiry, rigorous document review, and cross-validation with clinical and supply chain stakeholders. Primary inputs included structured interviews with procurement leaders, sterile processing managers, clinician champions across surgical specialties, and manufacturing quality leads, providing direct insight into specification drivers, evaluation protocols, and logistical constraints. These discussions informed qualitative assessments of product adoption dynamics, clinical usability concerns, and supplier performance attributes.

Secondary analysis encompassed standards documentation, peer-reviewed literature on barrier performance and infection prevention, industry white papers on nonwoven technology and textile processing, and regulatory guidance relevant to surgical apparel. Triangulation of these sources ensured that conclusions reflect consensus across clinical practice, product performance evidence, and regulatory expectations. Throughout the research process, emphasis was placed on traceable sourcing, validation of test methods, and alignment between stated product claims and independent performance evaluations.

Finally, findings were stress-tested through scenario analysis to explore the operational implications of supply disruptions, tariff changes, and rapid shifts in clinical demand. This methodological approach supports robust, actionable insight while acknowledging areas where further primary data collection could yield deeper specialty-specific or regional granularity.

A strategic conclusion emphasizing the integrated clinical, operational, and sustainability implications that should guide future gown procurement and product development

In conclusion, surgical gowns are evolving beyond their traditional role as disposable protective layers into strategically significant products that intersect clinical safety, operational resilience, and environmental stewardship. Material innovation, tightened regulatory expectations, and supply chain realignments are collectively influencing procurement criteria and clinician preferences. As a result, organizations must adopt a holistic approach to gown selection that incorporates barrier performance, user comfort, lifecycle impact, and supplier reliability.

Decision-makers should prioritize transparent performance data, rigorous clinical evaluation, and contractual safeguards that protect continuity of supply while enabling access to innovation. By aligning procurement practices with clinical needs and operational realities, healthcare institutions can reduce procedural risk, enhance clinician satisfaction, and strengthen resilience against external disruptions. Continued collaboration among manufacturers, healthcare providers, and standards bodies will be essential to drive incremental improvements in product design, validation methods, and sustainable practices that meet the evolving demands of surgical care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of antimicrobial silver nanoparticles in gown fabrics to enhance infection control
  • 5.2. Development of reusable surgical gowns with self-disinfecting surfaces for multiple procedure cycles
  • 5.3. Implementation of 3D knitting technology for seamless gown manufacturing and ergonomic fit
  • 5.4. Shift towards certified Level 4 sterilizable gowns compatible with radiation sterilization processes
  • 5.5. Increased demand for fluid-repellent breathable gowns tailored for minimally invasive surgical procedures
  • 5.6. Growth in near field communication tagging for real-time gown traceability in hospital supply chains
  • 5.7. Rising adoption of lightweight composite SMS and spunbond fabric blends to improve user comfort and protection

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Gown Market, by Product Type

  • 8.1. Disposable
  • 8.2. Reusable

9. Surgical Gown Market, by Sterility

  • 9.1. Non-Sterile
  • 9.2. Sterile

10. Surgical Gown Market, by Material

  • 10.1. Polyester-Cotton Blends
  • 10.2. Polyethylene-Coated Polypropylene
  • 10.3. Spunbond Polypropylene
  • 10.4. Spunbond-Meltblown-Spunbond

11. Surgical Gown Market, by Protection Level

  • 11.1. Level 1 (Minimal Risk)
  • 11.2. Level 2 (Low Risk)
  • 11.3. Level 3 (Moderate Risk)
  • 11.4. Level 4 (High Risk)

12. Surgical Gown Market, by Application

  • 12.1. Cardiovascular
  • 12.2. General Surgery
  • 12.3. Orthopedic

13. Surgical Gown Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Surgical Gown Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online

15. Surgical Gown Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Gown Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Gown Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. 3M Company
    • 18.3.2. Ahlstrom-Munksjo Oyj
    • 18.3.3. Cardinal Health, Inc.
    • 18.3.4. Delta Med S.p.A.
    • 18.3.5. Dispotech srl
    • 18.3.6. Lohmann & Rauscher GmbH & Co. KG
    • 18.3.7. Medica Europe B.V.
    • 18.3.8. Medline Industries, Inc.
    • 18.3.9. Molnlycke Health Care AB
    • 18.3.10. Paul Hartmann AG
    • 18.3.11. PRIMED Medical Products Inc.
    • 18.3.12. Shanghai Medical Corporation
    • 18.3.13. Steris Corporation
    • 18.3.14. Thermo Fisher Scientific Inc.
    • 18.3.15. Zhejiang Runtai Automation Technology Co.,Ltd.
    • 18.3.16. ANSELL LTD
    • 18.3.17. Kimberly-Clark Corporation
    • 18.3.18. DuPont de Nemours, Inc.
    • 18.3.19. B. Braun SE
    • 18.3.20. Halyard Health, Inc. by Owens & Minor Inc.
    • 18.3.21. TIDI Products, LLC
    • 18.3.22. Priontex (Pty) Ltd
    • 18.3.23. Sara Health Care Pvt Ltd
    • 18.3.24. Winner Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GOWN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SURGICAL GOWN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SURGICAL GOWN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SURGICAL GOWN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SURGICAL GOWN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL GOWN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL GOWN MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GOWN MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GOWN MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GOWN MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GOWN MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYESTER-COTTON BLENDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GOWN MARKET SIZE, BY POLYETHYLENE-COATED POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GOWN MARKET SIZE, BY SPUNBOND-MELTBLOWN-SPUNBOND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 1 (MINIMAL RISK), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 2 (LOW RISK), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 3 (MODERATE RISK), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GOWN MARKET SIZE, BY LEVEL 4 (HIGH RISK), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GOWN MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GOWN MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL GOWN MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL GOWN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL GOWN MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL GOWN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL GOWN MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL GOWN MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL GOWN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL GOWN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL GOWN MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL GOWN MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. GCC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GCC SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GCC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. GCC SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. GCC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 296. GCC SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 297. GCC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. GCC SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. GCC SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GCC SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GCC SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. G7 SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. G7 SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. G7 SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. G7 SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. G7 SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 340. G7 SURGICAL GOWN MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 341. G7 SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 342. G7 SURGICAL GOWN MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 343. G7 SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 344. G7 SURGICAL GOWN MARKET SIZE, BY PROTECTION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 345. G7 SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. G7 SURGICAL GOWN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 347. G7 SURGICAL GOWN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 348. G7 SURGICAL GOWN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 349. G7 SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 350. G7 SURGICAL GOWN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 351. NATO SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 352. NATO SURGICAL GOWN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 353. NATO SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. NATO SURGICAL GOWN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 355. NATO SURGICAL GOWN MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 356. NATO SURGICAL GOWN MARKET SIZE, BY STERI